Physiological Role of Mitogen-Activated Protein Kinase in Eye: Comparison
View Latest Version
Please note this is a comparison between Version 2 by Conner Chen and Version 4 by Conner Chen.

Mitogen-activated protein kinase (MAPK) pathways represent ubiquitous cellular signal transduction pathways that regulate all aspects of life (such as development of eye) and are frequently altered in disease. Once activated through phosphorylation, these MAPKs in turn phosphorylate and activate transcription factors present either in the cytoplasm or in the nucleus, leading to the expression of target genes and, as a consequence, they elicit various biological responses. 

  • MAPK
  • ERK
  • p38
  • JNK
  • eye
  • ocular
  • MEK
  • inhibitors

1. Introduction

The mitogen-activated protein kinase (MAPK or MAP kinase) family consists of protein kinases that phosphorylate their own dual serine (Ser) and threonine (Thr) residues (autophosphorylation), or those found on their substrate downstream kinases, to activate or de-activate their target [1]. MAPKs are ubiquitously expressed and evolutionarily conserved in eukaryotes. Each group of MAPKs contains a multi-tiered signaling cascade of kinases: at the top upstream level of the canonical MAPK pathways there are the MAPK kinase kinase kinases (MAPKKKKs, or MAP4Ks), which act upon MAPK kinase kinases (MAPKKK, or MAP3Ks), which then act in turn on MAPK kinases (MAPKKs, or MAP2Ks), with a final effector MAPK as their target (Figure 1). MAP3Ks are Ser/Thr protein kinases that are activated through phosphorylation., which, in turn, leads to the phosphorylation and activation of MAP2Ks in their Ser/Thr activation site (Ser-X-X-X-Ser/Thr motif). Activated MAP2Ks then stimulate MAPK activity through dual phosphorylation on Thr and Tyr residues within a conserved Thr-X-Tyr motif located in the activation loop of the MAPK domain [2] (Figure 1). A comprehensive list of MAPKs, MAP2Ks and MAPKs is presented in Table 1. MAPKs mainly include four subfamilies based on the conserved Thr-X-Tyr motif: ERK1/2, the JNK1/2/3, the p38 (α, β, γ, and δ), and the ERK5 branches, which are all ultimately activated by signaling cascades initiated by multiple factors such as growth factors and stress. More details on the signaling pathway members are given elsewhere [3]. Once activated through phosphorylation, these MAPKs in turn phosphorylate and activate an array of transcription factors present in the cytoplasm and nucleus, leading to the expression of target genes and resulting in a biological response. MAPKs are involved in multiple cellular processes, such as cell differentiation, proliferation, apoptosis, inflammation, stress responses, and immune defense [4]. In general, the activation of ERK by growth factors, hormones and proinflammatory stimuli promotes cell proliferation, whereas the activation of p38 and JNK by cellular and environmental stresses promotes multiple cellular processes such as proliferation, apoptosis, immunological effects, insulin signaling and neuronal activity [5]. The ERK pathway was the first MAPK cascade to be elucidated and is the best characterized. The canonical intracellular part of the activation pathway starts when a Ras GTPase exchanges a guanosine diphosphate (GDP) for a guanosine triphosphate (GTP) molecule [2]. This is facilitated upon the binding of extracellular mitogens to a cell surface receptor such as EGFR and the subsequent docking and activation of intracellular complexes, for instance GRB2-SOS [2]. This switching of Ras allows it to activate a MAP3K (e.g., Raf) and initiate the cascade of a MEK1/2 (MAP2Ks) and ERK1/2 (MAPK) activation (Figure 1). More generally, the ERK1/2 pathway is stimulated in mammalian cells by tyrosine kinase receptors and G-protein-coupled receptors through both Ras-dependent and Ras-independent pathways [6]. ERK1/2 is also activated by growth factors, mitogens, cytokines, osmotic stress, and in response to insulin [2]. Given its central role in cell proliferation, differentiation and survival, the MAPK pathway network and its inhibition has attracted great pharmacological interest in the context of cancer research, and a plethora of compounds have been developed/identified that can directly act on this pathway to influence cell fate.
Cells 12 00617 g001
Figure 1. Simplified schematic summary of the main MAPK signaling pathways.
Table 1. Summary of MAP kinases (up to MAP3Ks) with gene names, protein names and alternative names, the pathways they are known to interact with and their relative level at the signaling cascade.
Gene Name Protein Name Alternative Protein Names Pathway Involved MAPK Level Other Gene/Protein Names
MAPK1 ERK2 p42-MAPK MEK/ERK MAPK MAPK2, p38, p40, p41, ERT1, NS13
MAPK3 ERK1 p44-MAPK MEK/ERK MAPK ERT2, PRKM3
MAPK4 ERK4 p63-MAPK atypical MAPK MAPK PRKM4
MAPK6 ERK3 p97-MAPK atypical MAPK MAPK PRKM6, HsT17250
MAPK7 ERK5   ERK5 MAPK PRKM7, BMK1
MAPK8 JNK1 SAPK1 JNK MAPK PRKM8
MAPK9 JNK2 p54aSAPK JNK MAPK PRKM9
MAPK10 JNK3 p54bSAPK JNK MAPK PRKM10, SAPK1b, p493F12
MAPK11 p38 beta SAPK2, SAPK2B p38 MAPK PRKM11
MAPK12 p38 gamma ERK6, SAPK-3 p38 MAPK PRKM12
MAPK13 p38 delta SAPK4 p38 MAPK PRKM13
MAPK14 p38 alpha SAPK2A, Mxi2 p38 MAPK PRKM14, PRKM15, CSBP, EXIP
MAPK15 ERK7/8   atypical MAPK MAPK  
MAP2K1 MEK1 MKK1, MAPKK1 MEK/ERK MAP2K CFC3
MAP2K2 MEK2 MKK2, MAPKK2 MEK/ERK MAP2K CFC4
MAP2K3 MEK3 MKK3, MAPKK3 p38 MAP2K SAPKK2
MAP2K4 MEK4 MKK4, MAPKK4 JNK MAP2K SAPKK1, JNKK1, JNKK
MAP2K5 MEK5 MAPKK5 ERK5 MAP2K  
MAP2K6 MEK6 MKK6, MAPKK6 p38 MAP2K SAPKK3
MAP2K7 MEK7 MKK7, MAPKK7 JNK MAP2K SAPKK4, JNKK2
RAF1 c-Raf Raf-1 MEK/ERK MAP3K  
BRAF B-Raf BRAF-1, RAFB1 MEK/ERK MAP3K NS7
MAP3K1 MEKK1   JNK MAP3K  
MAP3K2 MEKK2 MEKK2B ERK5 MAP3K  
MAP3K3 MEKK3 MAPKKK3 ERK5 MAP3K  
MAP3K4 MEKK4 MAPKKK4   MAP3K MTK1, PRO0412
MAP3K5 ASK1 MEKK5, MAPKKK5 JNK and p38 MAP3K  
MAP3K6 ASK2 MEKK6, MAPKKK6   MAP3K  
MAP3K7 TAK1 MEKK7, TGF1a JNK and p38 MAP3K CSCF, FMD2
MAP3K8 MEKK8 Tpl-2, c-COT   MAP3K COT, EST, ESTF, AURA2
MAP3K9 MLK1 MEKK9   MAP3K PRKE1
MAP3K10 MLK2 MEKK10   MAP3K MST
MAP3K11 MLK3 MEKK11 JNK and p38 MAP3K PTK1, SPRK
MAP3K12 ZPK MEKK12   MAP3K DLK, MUK, HP09298
MAP3K13 LZK MEKK13 JNK MAP3K MLK
MAP3K14       MAP3K FTDCR1B, HS, HSNIK, NIK
MAP3K15 ASK3     MAP3K bA723P2.3
TAOK1 PSK2 MAP3K16, TAO1 JNK MAP3K DDIB, KFC-B, MARKK, hKFC-B
TAOK2 PSK MAP3K17, TAO2   MAP3K Tao2beta, PSK1-BETA
TAOK3   MAP3K18 p38 MAP3K DPK, JIK, hKFC-A
MAP3K19       MAP3K RCK, YSK4
MAP3K20 MLK7 mlklak, pk   MAP3K AZK, MLT, MRK, ZAK, SFMMP
MAP3K21 MLK4 dJ862P8.3   MAP3K  
The eye is the central organ of the visual system of animals, allowing vision and other, vision-independent photo-response functions by collecting light from the environment and converting the light information to neuronal impulses, ultimately terminating in the brain’s visual cortex. In vertebrates, this is achieved via a complex system of structures which are organized in a spherical organ and serve distinct roles.

2. Physiological Role of MAPKs in the Eye

MAPK/ERK signaling, as a master proliferation and cellular differentiation regulation pathway, is indispensable for the formation of the organism as a whole during development [7]. More precisely, ERK kinases play important roles in promoting embryonic survival and regulate the development of the eye in vertebrates. Of note, although the process depicted in Figure 2 is largely conserved within vertebrates, fish such as zebrafish do not form a lens pit and vesicle; rather, the cells from the lens placode proliferate and migrate inwards, directly forming a solid spherical mass that detaches from the surface ectoderm. The formation of the neural retina, RPE and the cornea follow the same process and lineage. In adult goldfish, ERKs are highly expressed in multiple ocular tissues including the lens epithelial cells, lens fiber cells and the retina, whereas its inhibition promotes early apoptosis, preventing the formation of the eye [8]. Underscoring the importance of the ERK pathway in development, all RASopathies, which are pathologies due to mutations in the RAS-MAPK pathway, are confined to only gain-of-function mutational defects that lead to inefficient inhibition of the pathway, while there is no documented RASopathy caused by mutational pathway knockout [9]; since such mutations should be more common than gain-of-function mutations, their absence signifies that when they occur, are most likely non-viable. Regarding ocular development, morphology and function, RASopathies present only minor clinical manifestations such as the appearance of Lisch nodules, which are aggregates of dendritic melanocytes forming papules in the iris [10]. Given its importance for cellular functions, MAPK/ERK signaling has been implicated in multiple organisms in the processes of wound healing and regeneration. For instance, ERK2 is essential for retinal pigment epithelium (RPE) cell proliferation in vitro [11][12]. Although in mammals, the RPE is post-mitotic in the adult, the mechanisms underlying RPE proliferation are important for stem cell applications and for developmental understanding. MEK–ERK signaling is strengthened by auto-regulation of the expression of constituent molecules in the pathway [13], but blockade of initial MEK–ERK signaling inhibits the cell-cycle re-entry of newt RPE cells [14], and after wounding in the adult newt [15]. The MEK pathway is also essential to switch adult newt RPE cells to neural cells. [16]. Regeneration of a complete neural retina can be achieved in larval Xenopus Leavis through the activation of the MAPK signaling pathway by administering exogenous FGF-2 [17]. In zebrafish, retina regeneration after injury depends on Müller glia (MG) dedifferentiation into a cycling population of multipotent progenitors via an EGFR/MAPK signal transduction cascade that regulates the expression of regeneration-associated genes such as PAX6 [18][19]. It should be noted, however, that mammals, unlike teleost fish, do not possess the innate ability for retinal regeneration; rather, mammals develop gliosis after retinal damage. Thus, this knowledge is relevant to humans in the context of stem cell research, the potential for interventions to induce regeneration, or in developmental research. During rat embryogenesis, the ERK1/2 pathway is required for the proper development of retino-geniculate connections [20]. FGF2 stimulates PAX6 expression during the induction of transdifferentiation of the RPE through a FGFR/MEK/ERK signaling cascade into a neural-like epithelium [21]. Similar transdifferentiation is obtained in chicks through the ectopic expression of a constitutively-activated allele of MEK-1 [22]. In the injured chick retina, the MG showed an accumulation of p-ERK1/2 [23]. Regarding the JNK activation pathway, the upstream kinases MKK4 and MKK7 have redundant and unique roles in molecular signaling that are important for retinal development, RGC maturation and the response to axonal injury signaling [24]. JNK and p38 phosphorylation is increased after retinal ischemia, mainly in amacrine, ganglion and bipolar cells while ERK is activated in MG cells [25]. Specific blockage of ERK and p38 phosphorylation, but not of JNK, prevents ischemia-induced apoptosis and improves retinal function in a rat model [25]. Other studies have demonstrated, for instance, that in vivo inhibition of p38 MAPK activity may be detrimental to injured photoreceptor cells [26]. Thus, the use of p38 MAPK inhibitors for therapeutic purposes must take into account the possible side effects. p38 is activated in retinal ganglion cells (RGCs) after optic nerve axotomy, and this activation is in the signaling pathway for RGC apoptosis [27]. MAPK also plays a significant role in MG cell proliferation and differentiation within the retina, in a stage-dependent manner. Prior work strongly supports a model whereby activation of the MAPK signaling pathway promotes the entry of progenitors into a MG cell differentiation pathway during embryonic retinal development, but not after birth [28]. For example, Shp2 protein phosphatase deletion abolished ERK phosphorylation in the neural retina, leading to extensive retinal cell death and degeneration. Additionally, Shp2 mediated a basal level of Ras-MAPK signaling in MG cells during postnatal development and in an adult retina under normal physiological conditions [29]. Also, the ERK1/2 and p38 MAPK pathways are key regulators of growth cone guidance in vitro [30]. Cells 12 00617 g002 Figure 2. Schematic overview of developmental events during mammalian eye development, and germ layer origin of structures in the eye. (A) The optic vesicle, derived from the neuroepithelium of ectodermal lineage, approaches the surface ectoderm where the lens placode (blue cells) forms at the area of proximity between the layers. (B) The optic vesicle forms the optic cup, by the concurrent invagination of both the lens placode, forming the lens pit, and the proximal layer of the optic vesicle to the surface ectoderm, forming the presumptive neural retina (red cells). (C) The lens pit closes up onto itself forming the lens vesicle, with the cells from the central part of the lens pit (blue cells) directed posteriorly, and the cells from the lens pit periphery (yellow cells) directed anteriorly. The optic cup continues to invaginate. (D) The invaginated (inner) layer of the optic cup differentiates into the neural retina (red cells), while the outer layer forms the retinal pigment epithelium, RPE (orange cells). Cells in the posterior surface of the lens vesicle elongate towards the opposite pole, forming the lens fibers and filling the central volume of the lens, while the cells on the anterior side form the lens anterior epithelium. The surface ectoderm closes after the lens vesicle detaches, and the now continuous surface ectoderm forms the cornea.

References

  1. Peti, W.; Page, R. Molecular basis of MAP kinase regulation. Protein Sci. 2013, 22, 1698–1710.
  2. Cargnello, M.; Roux, P.P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 2011, 75, 50–83.
  3. Braicu, C.; Buse, M.; Busuioc, C.; Drula, R.; Gulei, D.; Raduly, L.; Rusu, A.; Irimie, A.; Atanasov, A.G.; Slaby, O.; et al. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers 2019, 11, 1618.
  4. Jeffrey, K.L.; Camps, M.; Rommel, C.; Mackay, C.R. Targeting dual-specificity phosphatases: Manipulating MAP kinase signalling and immune responses. Nat. Rev. Drug Discov. 2007, 6, 391–403.
  5. Gkouveris, I.; Nikitakis, N.G. Role of JNK signaling in oral cancer: A mini review. Tumor Biol. 2017, 39, 1–9.
  6. Büscher, D.; Hipskind, R.A.; Krautwald, S.; Reimann, T.; Baccarini, M. Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages. Mol. Cell. Biol. 1995, 15, 466–475.
  7. Brown, J.L.; Sones, J.L.; Angulo, C.N.; Abbott, K.; Miller, A.D.; Boehm, U.; Roberson, M.S. Conditional loss of ERK1 and ERK2 results in abnormal placentation and delayed parturition in the mouse. Sci. Rep. 2019, 9, 9641.
  8. Li, L.; Wang, L.; Li, T.-T.; Li, X.; Huang, X.-Q.; Chen, X.-W.; Li, Z.-L.; Lv, X.-M.; Liu, F.-Y.; Luo, Z.-W.; et al. ERK Signaling Pathway Regulates Embryonic Survival and Eye Development in Goldfish, Carassius auratus. Curr. Mol. Med. 2013, 13, 959–967.
  9. Jafry, M.; Sidbury, R. RASopathies. Clin. Dermatol. 2020, 38, 455–461.
  10. Cao, H.; Alrejaye, N.; Klein, O.D.; Goodwin, A.F.; Oberoi, S. A review of craniofacial and dental findings of the RASopathies. Orthod. Craniofac. Res. 2017, 20 (Suppl. S1), 32–38.
  11. Hecquet, C.; Lefevre, G.; Valtink, M.; Engelmann, K.; Mascarelli, F. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation. Investig. Opthalmol. Vis. Sci. 2002, 43, 3091–3098.
  12. Yasumuro, H.; Sakurai, K.; Toyama, F.; Maruo, F.; Chiba, C. Implications of a Multi-Step Trigger of Retinal Regeneration in the Adult Newt. Biomedicines 2017, 5, 25.
  13. Kochańczyk, M.; Kocieniewski, P.; Kozłowska, E.; Jaruszewicz-Błońska, J.; Sparta, B.; Pargett, M.; Albeck, J.G.; Hlavacek, W.S.; Lipniacki, T. Relaxation oscillations and hierarchy of feedbacks in MAPK signaling. Sci. Rep. 2017, 7, 38244.
  14. Mizuno, A.; Yasumuro, H.; Yoshikawa, T.; Inami, W.; Chiba, C. MEK–ERK signaling in adult newt retinal pigment epithelium cells is strengthened immediately after surgical induction of retinal regeneration. Neurosci. Lett. 2012, 523, 39–44.
  15. Yoshikawa, T.; Mizuno, A.; Yasumuro, H.; Inami, W.; Vergara, M.N.; Del Rio-Tsonis, K.; Chiba, C. MEK-ERK and heparin-susceptible signaling pathways are involved in cell-cycle entry of the wound edge retinal pigment epithelium cells in the adult newt. Pigment Cell Melanoma Res. 2012, 25, 66–82.
  16. Susaki, K.; Chiba, C. MEK mediates in vitro neural transdifferentiation of the adult newt retinal pigment epithelium cells: Is FGF2 an induction factor? Pigment Cell Res. 2007, 20, 364–379.
  17. Vergara, M.N.; Del Rio-Tsonis, K. Retinal regeneration in the Xenopus laevis tadpole: A new model system. Mol. Vis. 2009, 15, 1000–1013.
  18. Wan, J.; Zhao, X.-F.; Vojtek, A.; Goldman, D. Retinal injury, growth factors, and cytokines converge on β-catenin and pStat3 signaling to stimulate retina regeneration. Cell Rep. 2014, 9, 285–297.
  19. Wan, J.; Ramachandran, R.; Goldman, D. HB-EGF is Necessary and Sufficient for Müller Glia Dedifferentiation and Retina Regeneration. Dev. Cell 2012, 22, 334–347.
  20. Naska, S.; Cenni, M.C.; Menna, E.; Maffei, L. ERK signaling is required for eye-specific retino-geniculate segregation. Development 2004, 131, 3559–3570.
  21. Spence, J.R.; Madhavan, M.; Aycinena, J.-C.; Del Rio-Tsonis, K. Retina regeneration in the chick embryo is not induced by spontaneous Mitf downregulation but requires FGF/FGFR/MEK/Erk dependent upregulation of Pax6. Mol. Vis. 2007, 13, 57–65.
  22. Galy, A.; Néron, B.; Planque, N.; Saule, S.; Eychène, A. Activated MAPK/ERK kinase (MEK-1) induces transdifferentiation of pigmented epithelium into neural retina. Dev. Biol. 2002, 248, 251–264.
  23. Fischer, A.J.; Scott, M.A.; Tuten, W. Mitogen-activated protein kinase-signaling stimulates Müller glia to proliferate in acutely damaged chicken retina. Glia 2009, 57, 166–181.
  24. Syc-Mazurek, S.B.; Rausch, R.L.; Fernandes, K.A.; Wilson, M.P.; Libby, R.T. Mkk4 and Mkk7 are important for retinal development and axonal injury-induced retinal ganglion cell death. Cell Death Dis. 2018, 9, 1095.
  25. Roth, S.; Shaikh, A.R.; Hennelly, M.M.; Li, Q.; Bindokas, V.; Graham, C.E. Mitogen-Activated Protein Kinases and Retinal is chemia. Investig. Opthalmol. Vis. Sci. 2003, 44, 5383–5395.
  26. Agca, C.; Gubler, A.; Traber, G.; Beck, C.; Imsand, C.; Ail, D.; Caprara, C.; Grimm, C. p38 MAPK signaling acts upstream of LIF-dependent neuroprotection during photoreceptor degeneration. Cell Death Dis. 2013, 4, e785.
  27. Kikuchi, M.; Tenneti, L.; Lipton, S.A. Role of p38 Mitogen-Activated Protein Kinase in Axotomy-Induced Apoptosis of Rat Retinal Ganglion Cells. J. Neurosci. 2000, 20, 5037–5044.
  28. Zhang, S.S.-M.; Li, H.; Huang, P.; Lou, L.X.; Fu, X.-Y.; Barnstable, C.J. MAPK signaling during Müller glial cell development in retina explant cultures. J. Ocul. Biol. Dis. Inform. 2010, 3, 129–133.
  29. Cai, Z.; Simons, D.L.; Fu, X.-Y.; Feng, G.-S.; Wu, S.M.; Zhang, X. Loss of Shp2-Mediated Mitogen-Activated Protein Kinase Signaling in Müller Glial Cells Results in Retinal Degeneration. Mol. Cell. Biol. 2011, 31, 2973–2983.
  30. Campbell, D.S.; Holt, C.E. Apoptotic Pathway and MAPKs Differentially Regulate Chemotropic Responses of Retinal Growth Cones. Neuron 2003, 37, 939–952.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
Video Production Service
Feedback